# Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction

> **NCT02344849** · PHASE1 · COMPLETED · sponsor: **Pharmicell Co., Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** mesenchymal stem cell

## Key facts

- **NCT ID:** NCT02344849
- **Lead sponsor:** Pharmicell Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2018-01-31
- **Final completion:** 2018-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02344849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02344849, "Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02344849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*